The Vita Coco Company, Inc. (COCO) Stock Price & Analysis

The Vita Coco Company, Inc. (COCO) closed at USD 59 on Thursday, October 22, 2026, down 7.09% on the day. The US market is currently closed (pre-market); this is not a live price.

The prior close was USD 63.5; the Oct 22, 2026 session ranged USD 57.81–63.09 on volume of 3,288,680 shares. Market capitalization is $3.41B, with a 52-week range of USD 39.6–85.83 (NMS). Source: Nexqual, retrieved October 23, 2026 at 10:37 UTC.

Also available as compact Markdown for AI agents: nexqual.com/COCO.md

Key facts (COCO)

• Last four reported quarters (through Sep 30, 2026): revenue $768M, net income $120M (15.7% margin), free cash flow $144M (SEC filings).
• Valuation: P/E 28.3x (avg 38.7x at the last 3 fiscal year-ends).
• 1 of 80 tracked superinvestors hold COCO (13F, Q2 2026): 0 new, 0 added, 1 reduced, 0 unchanged.
• Insider open-market sales, last ~7 months: 19 Form 4 filings, $55.3M; 0 not under a Rule 10b5-1 plan ($0K); 1 by opportunistic insiders (0 outside 10b5-1 plans), 9 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
• Analysts: Buy (mean 2.17 on a 1–5 scale) (12 analysts), mean target USD 79.1 (range 65–90).
• Total return with dividends: 1Y +44.4% vs S&P 500 +14.9%; 5Y +322.9% vs S&P 500 +80.3%.
• Next earnings: 2026-10-22, EPS estimate USD 0.22, revenue estimate $178M.

Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (COCO)

Fiscal years end Dec. EPS is split-adjusted.

Valuation (price ÷ last four quarters, through Sep 30, 2026) (COCO)

P/E 28.3x · P/S 4.5x · P/FCF 23.7x · P/B 8.0x · FCF yield 4.22% · Earnings yield 3.53% · Buyback yield (TTM) 1.86%

P/E at fiscal year-ends: Dec 2025 44.6x, Dec 2024 39.1x, Dec 2023 32.3x.

Superinvestors (SEC 13F-HR, Q2 2026) (COCO)

1 of 80 tracked investors hold COCO. Each row is the investor's latest 13F; change is vs their prior-quarter share count.

Insider sales (SEC Form 4, open-market, last ~7 months) (COCO)

19 of 19 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.

% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).

Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.

Analysts (COCO)

Consensus Buy (mean 2.17 on a 1–5 scale), 12 analysts; mean target USD 79.1 (low 65, high 90).

Rating changes, last 120 days:

Total return (dividends reinvested) (COCO)

COCO revenue by business segment (quarter ended Sep 30, 2026)

COCO revenue by product line (quarter ended Sep 30, 2026)

COCO revenue by region (quarter ended Mar 31, 2026)

As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).

COCO suppliers, customers and competitors (named in its 10-K)

Quoted from the company's 10-K filed Feb 18, 2026.

COCO customer concentration

In the period ended Sep 30, 2026, 2 direct customers each accounted for at least 10% (23%, 22%) of revenue, per the company's 10-Q filed Oct 22, 2026. The company does not name them.

COCO company outlook (results filed Oct 22, 2026)

• “Organic Net Sales Growth 1 of 18% Net Income Increased $11 million to $35 million and Non-GAAP Adjusted EBITDA² Increased $21 million to $53 million Raises Fiscal Year 2026 Guidance for Net Sales to Between $810 Million and $820 Million and Non-GAAP Adjusted EBITDA² to between $170 million and $175 million NEW YORK, NY – October 22, 2026 – The Vita Coco Company, Inc.”

Quoted word-for-word from the SEC 8-K results press release.

COCO analyst estimates and revisions

Key Statistics (as of October 23, 2026 at 10:37 UTC)

Technical Analysis (COCO)

Nexqual's technical model rates COCO "BUY" based on 4 bullish and 1 bearish signals across 127 daily candles, as of October 23, 2026 at 10:37 UTC.

Analyst Ratings (COCO)

Wall Street analysts rate COCO "Buy" based on 12 analysts, with a mean price target of USD 79.1 (range USD 65–90), per Nexqual as of October 23, 2026 at 10:37 UTC.

Earnings (COCO)

Recent Earnings History

Source: Nexqual, October 23, 2026 at 10:37 UTC.

Financials & Fundamentals (COCO)

Source: Nexqual, October 23, 2026 at 10:37 UTC.

Financial Health Score (COCO)

Nexqual rates The Vita Coco Company, Inc.'s overall financial health "Strong" across five dimensions, as of October 23, 2026 at 10:37 UTC.

Ownership (COCO)

Source: Nexqual, October 23, 2026 at 10:37 UTC.

From The Vita Coco Company, Inc.'s Latest SEC 10-K Filing (filed 2026-02-18)

Key Strengths & Strategy (as disclosed to the SEC)

• Vita Coco is the coconut water category leader with greater than 40% market share in the U.S. according to Circana US for the 52 weeks ended December 28, 2025, and over indexes to younger households and to more multicultural shoppers.
• Internationally, our business is anchored by Vita Coco's presence in the U.K., where it is the coconut water category leader with 80% market share, according to Circana UK, for the 52 weeks ended December 27, 2025.
• We are one of the largest brands globally in the coconut and other plant waters category, and a large supplier of Private Label coconut water.
• Through our access and relationships with coconut processors and manufacturers in many countries, including the Philippines, Brazil, Thailand, Vietnam, Malaysia, and Sri Lanka, we have built a unique body of knowledge and relationships that promote coconut water processing at scale, as well as gained access to farms across diversified geographies.

Partnerships

• Other countries are serviced through importers with limited retail direct relationships or in partnership with one of our manufacturing partners through licensing or other agreements.

Legal & Regulatory Risks (Item 1A, quoted)

• The occurrence of food-borne illnesses or other food safety incidents could also adversely affect the price and availability of affected ingredients and raw materials, resulting in higher costs, disruptions in supply and a reduction in our sales.
• Our products and operations are subject to state and government regulation and oversight both in the U.S. and abroad, and our failure to comply with applicable requirements, or to respond to changes in regulations applicable to our business could adversely affect our business, financial condition, results of operations and cash flows.
• The regulatory environment in which we operate could also change significantly and adversely in the future.
• Any loss of confidence on the part of consumers in the truthfulness of our labeling, advertising or ingredient claims would be difficult and costly to overcome and may significantly reduce our brand value.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 10:37 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt